A study in the journal Pediatrics evaluated the efficacy of primary BNT162b2, mRNA-1273, and heterologous mRNA Covid-19 vaccines in preventing hospitalization amongst adolescents in Sweden, Norway, Finland, and Denmark. It found that vaccine effectiveness against hospitalization ranged from 73% to 86% at six months, with the protection remaining consistent up to a year, including during the Omicron wave.
Digital Transformation in Healthcare Market Size, Share & Forecast to 2036 – Fact.MR
Digital Transformation in Healthcare Market Size, Share & Forecast to 2036 Fact.MR
